 |
| Source http://www.aptsci.com |
Aptamers are DNA or RNA particles that have been chosen from arbitrary pools dependent upon their capacity to tie different atoms. Aptamers have been chosen which tie nucleic corrosive, proteins, little natural mixes, and even whole organic entities. These novel atoms have numerous potential uses in pharmaceutical and innovation.
The aptamers market is analyzed both in terms of qualitative, i.e. technological and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected development rate.
 |
| Source : www.sec.gov |
The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production expense compared to antibodies aid the development of the market. However, the reduced market acceptance compared to the antibodies and increased time consumption for screening using SELEX will hamper the development of this market, to a certain extent. While aptamer technology has existed for over two decades, the challenges imposed on the development of aptamers for little molecules has resulted in very few novel aptamers that can bind to practical little molecular targets. Nevertheless, there are numerous opportunities for the innovative application of little molecule binding aptamers in biosensing, drug discovery, diagnostics and therapeutics.
Besides a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are likewise discussed. Research applications are specifically discussed regarding aptamers use in stream cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.
Besides a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are likewise discussed. Research applications are specifically discussed regarding aptamers use in stream cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.
 |
| Source: www.marketsandmarkets.com |
In the year 2012 the global aptamers market was valued at $200 million. The market is worth $287 million and is expected to reach approximately $2.1 billion by 2018, growing at a CAGR of
49.24% from 2013 to 2018, at the end of 2013.
For more details visit :
I want to share a testimony on how Le_Meridian funding service helped me with loan of 2,000,000.00 USD to finance my marijuana farm project , I'm very grateful and i promised to share this legit funding company to anyone looking for way to expand his or her business project.the company is UK/USA funding company. Anyone seeking for finance support should contact them on lfdsloans@outlook.com Or lfdsloans@lemeridianfds.com Mr Benjamin is also on whatsapp 1-989-394-3740 to make things easy for any applicant.
ReplyDelete